COVID – 19 | Vaccination Update – Day 396

ad
Adults don't need tetanus, diphtheria boosters if fully vaccinated as children
Adults don't need tetanus, diphtheria boosters if fully vaccinated as children

India’s COVID-19 vaccination coverage has reached nearly 174 Crore (1,73,82,43,994today. More than 37 lakh (37,69,847Vaccine Doses have been administered till 7 pm today. More than 1.79 Crore (1,79,58,242) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10399914
2nd Dose 9939364
Precaution Dose 3945483
FLWs 1st Dose 18406215
2nd Dose 17392371
Precaution Dose 5569902
Age Group 15-18 years 1st Dose 52675493
2nd Dose 17502891
Age Group 18-44 years 1st Dose 548995823
2nd Dose 429811334
Age Group 45-59 years 1st Dose 201804547
2nd Dose 177038471
Over 60 years 1st Dose 126022295
2nd Dose 110297034
Precaution Dose 8442857
Cumulative 1st dose administered 958304287
Cumulative 2nd dose administered 761981465
Precaution Dose 17958242
Total 1738243994

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 15th February, 2022 (396th Day)
HCWs 1st Dose 179
2nd Dose 3019
Precaution Dose 28867
FLWs 1st Dose 412
2nd Dose 6347
Precaution Dose 99373
Age Group 15-18 years 1st Dose 225747
2nd Dose 1048431
Age Group 18-44 years 1st Dose 306529
2nd Dose 1314248
Age Group 45-59 years 1st Dose 55249
2nd Dose 285489
Over 60 years 1st Dose 42562
2nd Dose 174755
Precaution Dose 178640
Cumulative 1st dose administered 630678
Cumulative 2nd dose administered 2832289
Precaution Dose 306880
Total 3769847

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply